E. Özkan, “Baseline and dynamic changes in skeletal muscle mass as predictive biomarkers in patients with metastatic renal cell carcinoma treated with Nivolumab: Predictive Value of Sarcopenia in mRCC”, Radiol Oncol, vol. 59, no. 4, pp. 624–634, Dec. 2025.